2022 Barclays Global Consumer Staples Conference
Logotype for Church & Dwight Co Inc

Church & Dwight (CHD) 2022 Barclays Global Consumer Staples Conference summary

Event summary combining transcript, slides, and related documents.

Logotype for Church & Dwight Co Inc

2022 Barclays Global Consumer Staples Conference summary

14 Nov, 2026

Growth model and portfolio

  • Evergreen targets: domestic organic sales +2%, international +6%, SPD +5%; gross margin +25 bps, SG&A -25 bps, operating margin +50 bps and EPS growth +8%.

  • Ten-year average organic sales growth was 4.3% vs. a 3% target; average EPS growth was 10.6% vs. an 8% target.

  • Fifteen power brands represent more than 85% of sales and profits; the portfolio mix is 40% value and 60% premium.

  • Acquisition criteria prioritize #1 or #2 brands, higher growth and margins, asset-light businesses, use of existing capabilities and sustainable competitive advantage.

Category trends

  • Liquid laundry detergent category growth moderated in 2022, while Arm & Hammer consumption accelerated; the brand reached an all-time share high in August.

  • Consumers were shifting from premium to value liquid laundry detergent amid recessionary conditions.

  • Cat litter showed strong category growth and stronger Arm & Hammer consumption; vitamins and supplements slowed, with branded consumption trailing category trends.

  • Power oral care above $20 contracted as consumers pulled back or traded down; dry shampoo grew at double-digit rates, led by Batiste, and TheraBreath drove strong alcohol-free mouthwash growth.

  • Case fill rates improved from below 80% in Q1 toward 93%-95% by year-end, with improvement expected to support second-half category and share performance.

Hero acquisition and growth opportunity

  • Hero was the #2 acne care brand in the U.S. and the #1 acne patch brand, with 63% share of the patch category, over 5x its next closest competitor.

  • Hero household penetration was 4.4% vs. 23% for acne care overall; current ACV distribution was 8%, with a goal of 80%-90%.

  • The planned $630 million acquisition had trailing 12-month sales of $115 million and EBITDA of about $45 million, a 40% margin; expected to close in Q4, subject to customary conditions.

  • Hero was expected to add 3% to cash earnings and be neutral to adjusted 2023 EPS, including transition costs; leverage was projected at 2.0x exiting 2022 and below 2.0x in 2023.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Church & Dwight